This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

REPORT OF A CASE

D. KIRKHAM, M.D.; MARTIN PERLMUTTER, M.D.

Arch Derm Syphilol. 1941;43(1):111-115.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Mapharsen has recently become a favorite drug in the treatment of syphilis and is replacing other arsenical compounds in many clinics. Among many papers on its properties and effectiveness, probably the most comprehensive are those of Gruhzit and Dixon¹ and Cole and Palmer.² It is generally regarded as a safer drug than arsphenamine or neoarsphenamine. Stephenson and Wingo³ reported that 12,860 doses of mapharsen were given in the United States Navy between Jan. 1, 1935 and Dec. 31, 1937, with only 1 serious reaction. This reaction was in a case in which neoarsphenamine had caused an exfoliative dermatitis. Ten years later a single dose of mapharsen caused a recurrence, from which the patient recovered after twenty-four days in the hospital. In contrast to this record of no deaths and only 1 serious reaction following 12,860 doses of mapharsen is the report by the same author of a . . . [Full Text PDF of this Article]

Author Affiliations
BROOKLYN

From the Long Island College Division of the Kings County Hospital and from the Department of Medicine, Long Island College of Medicine.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?